Leigh Boulware to Survival Rate
This is a "connection" page, showing publications Leigh Boulware has written about Survival Rate.
Connection Strength
0.161
-
Boulware LE, Tangri N, Ephraim PL, Scialla JJ, Sozio SM, Crews DC, Shafi T, Miskulin DC, Liu J, St Peter W, Jaar BG, Wu AW, Powe NR, Navaneethan SD, Bandeen-Roche K. Comparative effectiveness studies to improve clinical outcomes in end stage renal disease: the DEcIDE patient outcomes in end stage renal disease study. BMC Nephrol. 2012 Dec 06; 13:167.
Score: 0.089
-
Crews DC, Scialla JJ, Boulware LE, Navaneethan SD, Nally JV, Liu X, Arrigain S, Schold JD, Ephraim PL, Jolly SE, Sozio SM, Michels WM, Miskulin DC, Tangri N, Shafi T, Wu AW, Bandeen-Roche K. Comparative effectiveness of early versus conventional timing of dialysis initiation in advanced CKD. Am J Kidney Dis. 2014 May; 63(5):806-15.
Score: 0.024
-
Miskulin DC, Zhou J, Tangri N, Bandeen-Roche K, Cook C, Ephraim PL, Crews DC, Scialla JJ, Sozio SM, Shafi T, Jaar BG, Boulware LE. Trends in anemia management in US hemodialysis patients 2004-2010. BMC Nephrol. 2013 Dec 01; 14:264.
Score: 0.024
-
St Peter WL, Sozio SM, Shafi T, Ephraim PL, Luly J, McDermott A, Bandeen-Roche K, Meyer KB, Crews DC, Scialla JJ, Miskulin DC, Tangri N, Jaar BG, Michels WM, Wu AW, Boulware LE. Patterns in blood pressure medication use in US incident dialysis patients over the first 6 months. BMC Nephrol. 2013 Nov 12; 14:249.
Score: 0.024